EUCOPE News

News - June 22, 2018

Joint pharmaceutical industry statement on the Commission’s proposal for a Regulation on health technology assessment (HTA)

The pharmaceutical industry represented by AESGP[1], EFPIA[2], EUCOPE[3], EuropaBio[4], Medicines for Europe and PPTA[5] – henceforth referred to as ‘the pharmaceutical industry’ – generally welcomes the European Commission (EC)’s Proposal for a Regulation on HTA[6]. We understand the scope of… read more

---

News - April 19, 2018

Better regulation, SMEs and intellectual property: there is work to be done!

On 13 March 2018, EUCOPE co-organised with Comitology.eu a breakfast discussion on “Future proofing EU policies for SMEs –  a Case Study on Intellectual Property Rights”. Attended by over 30 commercial and institutional stakeholders as well as press and academia,… read more

---

News - March 23, 2018

Associations representing the European and British life science industry respond to the European Council approving terms of the transition period agreed between the UK Government and EU

The associations representing the European and British life science industry (AESGP, ABPI, BIA, BGMA, EBE, EFPIA, EUCOPE, EuropaBio, Medicines for Europe, PAGB, Vaccines Europe) have today responded to the European Council approving terms of the transition period agreed between the… read more

---

News - December 14, 2017

Joint policy document on the potential impact of the UK’s exiting the EU by the associations representing the European and British life science industry

The associations representing the European and British life science industry (AESGP, ABPI, BIA, BGMA, EBE, EFPIA, EUCOPE, EuropaBio, Medicines for Europe, PAGB, Vaccines Europe) have today launched a joint policy document on the potential impact of the United Kingdom’s exiting… read more

---

News - December 14, 2017

EUCOPE and other associations representing the European and British life science industry launch a joint policy document on the potential impact of the UK’s exiting the EU

The associations representing the European and British life science industry (AESGP, ABPI, BIA, BGMA, EBE, EFPIA, EUCOPE, EuropaBio, Medicines for Europe, PAGB, Vaccines Europe) have today launched a joint policy document on the potential impact of the United Kingdom’s exiting… read more

---

News - December 7, 2017

European health community calls on the EU and UK to prioritise patients as crunch Article 50 decision approaches

Today a group of organisations representing patients, healthcare professionals and the health care industry have called on the EU and UK to prioritise patients in the Brexit negotiations. To coincide with the EPSCO Council of EU Health Ministers in Brussels,… read more

---

News - December 7, 2017

European health community calls on the EU and UK to prioritise patients as crunch Article 50 decision approaches

Today a group of organisations representing patients, healthcare professionals and the health care industry have called on the EU and UK to prioritise patients in the Brexit negotiations. To coincide with the EPSCO Council of EU Health Ministers in Brussels,… read more

---

News - September 12, 2017

Joint policy document on the potential impact of the UK’s exiting the EU by the associations representing the European and British life science industry

The associations representing the European and British life science industry (AESGP, ABPI, BIA, BGMA, EBE, EFPIA, EUCOPE, EuropaBio, Medicines for Europe, PAGB, Vaccines Europe) have today launched a joint policy document on the potential impact of the United Kingdom’s exiting… read more

---